Abstract
Abstract This is an expository paper which reviews the rationale for determining prognostic factors and the statistical methods for finding and allowing for such factors in the design and analysis of clinical studies. The delineation of prognostic factors in clinical studies is useful: in possibly providing insight into the mechanism of disease; in the determination of stratifications of patients for planning clinical trials; in facilitating the comparison between the outcomes of disease in different groups of patients; in assisting in the allocation of treatment to an individual patient and in permitting remedial action. A response variable is a measure of the future health or illness of the patient and its value is usually dependent on one or more prognostic variables. Statistical methodology for determining prognostic factors is reviewed for the case in which response is dichotomous, continuous or a measure of time (with the possibility of censored observations) and when the predictor variables are discrete or continuous (or a combination of both types). Methods of allowing for known prognostic variables in the analysis of a study are reviewed. These include: grouping of patients according to prognostic variables and comparing treatments separately within each group; covariance analysis and maximum likelihood. Knowledge of prognostic factors is useful in defining a control group which is to be compared with a treated group in non‐randomized studies. Three examples of studies designed to elucidate prognostic factors are described, one each in breast cancer, cancer of the prostate and Hodgkin's disease.
Keywords
Affiliated Institutions
Related Publications
Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801
Purpose To determine the added value of quality of life (QOL) as a prognostic factor for overall survival (OS) in patients with locally advanced non–small-cell lung cancer (NSCL...
The Design and Analysis of Sequential Clinical Trials.
Clinical Trials. Allocating Patients to Treatments. Measurement of Treatment Difference. The Design of a Sequential Trial Using the Boundaries Approach. The Analysis of a Sequen...
Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
In controlled clinical trials there are usually several prognostic factors known or thought to influence the patient's ability to respond to treatment. Therefore, the method of ...
Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67
Abstract To assess the prognostic significance of the growth fraction in diffuse large cell lymphoma (DLCL), we studied 105 DLCL patients with the monoclonal antibody Ki-67 appl...
Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease
Abstract Background Since early December 2019, the 2019 novel coronavirus disease (COVID-19) has caused pneumonia epidemic in Wuhan, Hubei province of China. This study aimed to...
Publication Info
- Year
- 1974
- Type
- review
- Volume
- 13
- Issue
- 1
- Pages
- 16-36
- Citations
- 137
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1002/ijc.2910130104